Managing Anemia in Chronic Kidney Disease
Author Information
Author(s): Rebecca J Schmidt, Cheryl L Dalton
Primary Institution: West Virginia University Health Sciences Center
Hypothesis
Can treating anemia of chronic kidney disease with erythropoietic agents improve cardiovascular outcomes?
Conclusion
Treating anemia in chronic kidney disease can improve patient outcomes, but careful management is necessary to avoid potential risks.
Supporting Evidence
- Anemia is linked to increased cardiovascular risk and mortality in chronic kidney disease patients.
- More than 60% of patients with CKD-related anemia are treated by primary care physicians.
- Early intervention in anemia management can improve quality of life and reduce hospitalizations.
Takeaway
Anemia is a common problem for people with kidney disease, and treating it can help them feel better and live longer, but doctors need to be careful about how they treat it.
Methodology
This review analyzes observational and randomized studies regarding the treatment of anemia in chronic kidney disease.
Potential Biases
Potential bias in the selection of studies and reporting of outcomes.
Limitations
The review may not cover all recent studies and findings related to anemia treatment in chronic kidney disease.
Participant Demographics
The study includes adults with chronic kidney disease, with a focus on those not requiring dialysis.
Statistical Information
P-Value
0.03
Confidence Interval
95% CI 1.03 to 1.74
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website